To collect the safety and efficacy data in patients with metastatic colorectalcancer after giving regorafenib in Indianpatients.
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary outcome(s): 1 AEs 2 changes in ECOG PS from baseline 3 laboratory changes 4 changes in vital signsTimepoint: From the start of regorafenib treatment up to 30 days after the last dose of regorafenib.
创建时间：
2018-07-15
